Article
Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management
Psoriasis: Targets and Therapy · 2022 · Al-Janabi A, Yiu ZZN
Key facts
| Title | Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management |
|---|---|
| First author | Al-Janabi A, Yiu ZZN |
| Journal | Psoriasis: Targets and Therapy |
| Published | Jan 6, 2022 |
| DOI | 10.2147/PTT.S328575 |
| Devices mentioned | 202136, 212196, 217927 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1